Literature DB >> 19696224

Beta-catenin promotes survival of renal epithelial cells by inhibiting Bax.

Zhiyong Wang1, Andrea Havasi, Jonathan M Gall, Haiping Mao, John H Schwartz, Steven C Borkan.   

Abstract

Ischemia activates Bax, a proapoptotic BCL2 protein, as well as the prosurvival beta-catenin/Wnt signaling pathway. To test the hypothesis that beta-catenin/Wnt signaling regulates Bax-mediated apoptosis after induction of metabolic stress, which occurs during renal ischemia, we infected immortalized and primary proximal tubular epithelial cells with adenovirus to express either constitutively active or dominant negative beta-catenin constructs. Constitutively active beta-catenin significantly decreased apoptosis and improved cell survival after metabolic stress. Furthermore, active beta-catenin decreased Bax activation, oligomerization, and translocation to mitochondria, and reduced both organelle membrane injury and apoptosis. Dominant negative beta-catenin had the opposite effects. Because Akt regulates Bax, we examined the effects of the beta-catenin mutants on Akt expression and activation. Constitutively active beta-catenin increased Akt-1 expression and activation before and after stress, and treatment with a phosphatidylinositol-3 kinase inhibitor antagonized the protective effects of beta-catenin on Akt activation, Bax inhibition, and cell survival. In addition, beta-catenin significantly increased the rate of phosphorylation at Bax serine(184), an Akt-specific target. Taken together, these results suggest that beta-catenin/Wnt signaling promotes survival of renal epithelial cells after metabolic stress, in part by inhibiting Bax in a phosphatidylinositol-3 kinase/Akt-dependent manner.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19696224      PMCID: PMC2736777          DOI: 10.1681/ASN.2009030253

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN: 1046-6673            Impact factor:   10.121


  59 in total

Review 1.  Mechanism and function of signal transduction by the Wnt/beta-catenin and Wnt/Ca2+ pathways.

Authors:  J R Miller; A M Hocking; J D Brown; R T Moon
Journal:  Oncogene       Date:  1999-12-20       Impact factor: 9.867

2.  Signal transduction of MEK/ERK and PI3K/Akt activation by hypoxia/reoxygenation in renal epithelial cells.

Authors:  Dae Sik Kwon; Chae Hwa Kwon; Jae Ho Kim; Jae Suk Woo; Jin Sup Jung; Yong Keun Kim
Journal:  Eur J Cell Biol       Date:  2006-07-24       Impact factor: 4.492

3.  Opposing effects of Bad phosphorylation at two distinct sites by Akt1 and JNK1/2 on ischemic brain injury.

Authors:  Xiao-Tian Wang; Dong-Sheng Pei; Jing Xu; Qiu-Hua Guan; Ya-Feng Sun; Xiao-Mei Liu; Guang-Yi Zhang
Journal:  Cell Signal       Date:  2007-04-27       Impact factor: 4.315

4.  Hsp27 inhibits Bax activation and apoptosis via a phosphatidylinositol 3-kinase-dependent mechanism.

Authors:  Andrea Havasi; Zhijian Li; Zhiyong Wang; Jody L Martin; Venugopal Botla; Kathleen Ruchalski; John H Schwartz; Steven C Borkan
Journal:  J Biol Chem       Date:  2008-02-25       Impact factor: 5.157

5.  Selective degradation of E-cadherin and dissolution of E-cadherin-catenin complexes in epithelial ischemia.

Authors:  K T Bush; T Tsukamoto; S K Nigam
Journal:  Am J Physiol Renal Physiol       Date:  2000-05

6.  ATP depletion increases tyrosine phosphorylation of beta-catenin and plakoglobin in renal tubular cells.

Authors:  J H Schwartz; T Shih; S A Menza; W Lieberthal
Journal:  J Am Soc Nephrol       Date:  1999-11       Impact factor: 10.121

7.  Bad as a converging signaling molecule between survival PI3-K/Akt and death JNK in neurons after transient focal cerebral ischemia in rats.

Authors:  Hiroshi Kamada; Chikako Nito; Hidenori Endo; Pak H Chan
Journal:  J Cereb Blood Flow Metab       Date:  2006-07-05       Impact factor: 6.200

8.  Mitochondrial dysfunction during hypoxia/reoxygenation and its correction by anaerobic metabolism of citric acid cycle intermediates.

Authors:  J M Weinberg; M A Venkatachalam; N F Roeser; I Nissim
Journal:  Proc Natl Acad Sci U S A       Date:  2000-03-14       Impact factor: 11.205

9.  p53 independent induction of PUMA mediates intestinal apoptosis in response to ischaemia-reperfusion.

Authors:  Bin Wu; Wei Qiu; Peng Wang; Hui Yu; Tao Cheng; Gerard P Zambetti; Lin Zhang; Jian Yu
Journal:  Gut       Date:  2006-11-24       Impact factor: 23.059

10.  Noncanonical Wnt signaling promotes apoptosis in thymocyte development.

Authors:  Huiling Liang; Andrew H Coles; Zhiqing Zhu; Jennifer Zayas; Roland Jurecic; Joonsoo Kang; Stephen N Jones
Journal:  J Exp Med       Date:  2007-12-10       Impact factor: 14.307

View more
  54 in total

1.  Induction of heat shock protein 70 inhibits ischemic renal injury.

Authors:  Zhiyong Wang; Jonathan M Gall; Ramon G B Bonegio; Andrea Havasi; Clayton R Hunt; Michael Y Sherman; John H Schwartz; Steven C Borkan
Journal:  Kidney Int       Date:  2011-01-26       Impact factor: 10.612

2.  Recognition-dependent signaling events in response to apoptotic targets inhibit epithelial cell viability by multiple mechanisms: implications for non-immune tissue homeostasis.

Authors:  Vimal A Patel; Lanfei Feng; Daniel J Lee; Donald Massenburg; Goutham Pattabiraman; Angelika Antoni; John H Schwartz; Wilfred Lieberthal; Joyce Rauch; David S Ucker; Jerrold S Levine
Journal:  J Biol Chem       Date:  2012-03-06       Impact factor: 5.157

3.  Drp1 dephosphorylation in ATP depletion-induced mitochondrial injury and tubular cell apoptosis.

Authors:  Sung-Gyu Cho; Quansheng Du; Shuang Huang; Zheng Dong
Journal:  Am J Physiol Renal Physiol       Date:  2010-04-21

4.  Obesity and hyperglycemia lead to impaired post-ischemic recovery after permanent ischemia in mice.

Authors:  Jatin Tulsulkar; Shadia E Nada; Brandon D Slotterbeck; Marcia F McInerney; Zahoor A Shah
Journal:  Obesity (Silver Spring)       Date:  2015-12-23       Impact factor: 5.002

5.  An interactive resource to identify cancer genetic and lineage dependencies targeted by small molecules.

Authors:  Amrita Basu; Nicole E Bodycombe; Jaime H Cheah; Edmund V Price; Ke Liu; Giannina I Schaefer; Richard Y Ebright; Michelle L Stewart; Daisuke Ito; Stephanie Wang; Abigail L Bracha; Ted Liefeld; Mathias Wawer; Joshua C Gilbert; Andrew J Wilson; Nicolas Stransky; Gregory V Kryukov; Vlado Dancik; Jordi Barretina; Levi A Garraway; C Suk-Yee Hon; Benito Munoz; Joshua A Bittker; Brent R Stockwell; Dineo Khabele; Andrew M Stern; Paul A Clemons; Alykhan F Shamji; Stuart L Schreiber
Journal:  Cell       Date:  2013-08-29       Impact factor: 41.582

6.  Targeted inhibition of β-catenin/CBP signaling ameliorates renal interstitial fibrosis.

Authors:  Sha Hao; Weichun He; Yingjian Li; Hong Ding; Yayi Hou; Jing Nie; Fan Fan Hou; Michael Kahn; Youhua Liu
Journal:  J Am Soc Nephrol       Date:  2011-08-04       Impact factor: 10.121

7.  Nucleophosmin Phosphorylation as a Diagnostic and Therapeutic Target for Ischemic AKI.

Authors:  Zhiyong Wang; Erdjan Salih; Chinaemere Igwebuike; Ryan Mulhern; Ramon G Bonegio; Andrea Havasi; Steven C Borkan
Journal:  J Am Soc Nephrol       Date:  2019-01       Impact factor: 10.121

8.  Impaired wound healing in hypoxic renal tubular cells: roles of hypoxia-inducible factor-1 and glycogen synthase kinase 3β/β-catenin signaling.

Authors:  Jianping Peng; Ganesan Ramesh; Lin Sun; Zheng Dong
Journal:  J Pharmacol Exp Ther       Date:  2011-10-18       Impact factor: 4.030

9.  Blocking TGF-β and β-Catenin Epithelial Crosstalk Exacerbates CKD.

Authors:  Stellor Nlandu-Khodo; Surekha Neelisetty; Melanie Phillips; Marika Manolopoulou; Gautam Bhave; Lauren May; Peter E Clark; Haichun Yang; Agnes B Fogo; Raymond C Harris; M Mark Taketo; Ethan Lee; Leslie S Gewin
Journal:  J Am Soc Nephrol       Date:  2017-07-12       Impact factor: 10.121

10.  Cadmium induces Wnt signaling to upregulate proliferation and survival genes in sub-confluent kidney proximal tubule cells.

Authors:  Prabir K Chakraborty; Wing-Kee Lee; Malte Molitor; Natascha A Wolff; Frank Thévenod
Journal:  Mol Cancer       Date:  2010-05-08       Impact factor: 27.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.